New antibiotic discovered in tropical forest

An international team of scientists has discovered a soil-borne antibiotic produced by the Mexican rainforest that can help produce phytonutrients, as well as help synthesize some new probiotic compounds. .

According to Nature Communications, a scientific team of researchers from Russia, the United States and France has discovered an antibiotic caused by bacteria in the soil from the Mexican rainforest . A new drug could help create phytonutrients, as well as help synthesize some new probiotic compounds.

Picture 1 of New antibiotic discovered in tropical forest
Tropical forests are where scientists have discovered an antibiotic produced by bacteria in the soil.

Probiotics are substances that ensure the conditions for the normal functioning of the human microflora can also be useful for plants, keeping them healthier and stronger.A new antibiotic called phazolicin helps prevent harmful bacteria from entering the legume root system.

The scientists hope the newly discovered bacterium could be used as a plant-derived bacterium, because phasolycin will prevent the growth of disease-causing organisms in the plant's root system.

Antimicrobial resistance is a huge problem both in medicine and agriculture. Continuing to find new antibiotics is important, as they may be the key to creating antibacterial drugs in the future.

The bacterium that produces phazolicin belongs to the genus Rhizobium and has not been scientifically described. It is found in a rainforest in the southern state of Veracruz in the soil and roots of Phaseolus Vulgaris wild legumes . Therefore, the new name of the new antibiotic is phazolicin.

Like other Rhizobium, phazolicin-producing bacteria form nodules on the roots of legumes and give them nitrogen, making them more stable. But unlike other bacteria of this genus, it also protects plants from phazolicin-sensitive pathogens.

By analyzing biological information, scientists predict the existence of phasolycin and then confirm this in the laboratory. They showed the atomic structure of the new antibiotic and found its mechanism of action, which is involved in the destruction of ribosomes in bacteria.